# A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

> clinical trial · VERIFIED · 2026-08-28

Status: RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Multiple Myeloma

- Company: Janssen Research & Development, LLC
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07518186

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.